Published online Nov 24, 2022. doi: 10.5306/wjco.v13.i11.907
Peer-review started: July 28, 2022
First decision: September 5, 2022
Revised: September 8, 2022
Accepted: November 6, 2022
Article in press: November 6, 2022
Published online: November 24, 2022
Processing time: 115 Days and 7.9 Hours
Chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC) rates are rising. Pancreatitis admissions costed 133 million dollars, and accounted for the 3rd leading cause of hospital admissions. There is lack of data identifying those at highest risk for admissions with CP and PDAC.
The main motivation of this study was to establish racial risk factors and their associations with PDAC.
This study had the objective to examine the demographic, ethno-racial, socioeconomic, and hospital factors associated with hospitalizations for CP and its association with PDAC.
This retrospective study used the 2016 and 2017 National Inpatient Sample databases. ICD-10 codes compatible with CP and PDAC were used in the study. The ethnic, socioeconomic, and racial backgrounds of patients with CP and PDAC were analyzed.
Hospital admissions for CP was 29 per 100000, and 2890 (0.78%) had PDAC. Blacks [adjusted odds ratio (aOR) 1.13], men (aOR 1.35), age 40 to 59 (aOR 2.60), and being overweight (aOR 1.34) were significantly associated with CP (all with P < 0.01). In patients with CP, Whites (aOR 1.23), higher income, older age (aOR 1.05), and being overweight (aOR 2.40) were all significantly associated with PDAC (all with P < 0.01). Men (aOR 1.81) and Asians (aOR 15.19) had significantly increased mortality (P < 0.05). Hispanics had significantly increased hospital length of stay (aOR 5.24) (P < 0.05).
There is an increased trend in hospitalization rates for CP, predominantly among black men between 40-59 years old who were overweight. Wealthy white men above the age of 40 had a higher PDAC diagnosis.
Black men between 40-59 years old and overweight are at significantly increased risk for admission with CP. White men with higher income were found to have significantly increased risk for admissions with CP and PDAC. Asians/Pacific Islanders had the highest risk for mortality from CP and PDAC.